Oppenheimer, unable to get response from Himax, stays at Underperform
Oppenheimer analyst Andrew Uerkwitz maintains an Underperform rating on Himax Technologies with a $4 price target. In a post-earnings research note titled "Time to Ask the Hard Questions," the analyst notes that he has tried to engage with management. but have not been able to start a conversation with them. The analyst notes that he queued up to ask a question on the earnings call and also reached out via email. In both cases, he didn't get a response. Uerkwitz continues to believe consensus estimates reflect "unrealistic optimism" in Himax's ability to execute the plan to commercialize the "total 3D sensing solution" for Android manufacturers in 2018.